First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome
Clinical trial NCT03594955 · TERMINATED
Trial details
- NCT number
- NCT03594955
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2021-02-06
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.